<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04393090</url>
  </required_header>
  <id_info>
    <org_study_id>CAN-17-01</org_study_id>
    <nct_id>NCT04393090</nct_id>
  </id_info>
  <brief_title>eHealth for the Elderly</brief_title>
  <acronym>My-eStEPs</acronym>
  <official_title>Multiple Myeloma Patients and Their HCPs Tested eHealth Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cankado Service GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cankado Service GmbH</source>
  <brief_summary>
    <textblock>
      Since internet usage as a complementing element in cancer care is becoming more and more
      important in oncological routine we launched My-eStEPs (eHealth Strategy for Elderly Patients
      with Multiple Myeloma) to investigate how specifically elderly patients and their Healthcare
      Professionals (HCPs) adopt electronic Health (eHealth) support during outpatient treatment.
      The purpose of this project is to explore how eHealth support influences patients'
      interaction with their HCPs and how both can benefit from this.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of patient's internet use</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluated in the following criteria: daily, at least once per week, at least once per month, less than once per month</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Purpose of patient's internet use</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluated in the following criteria: news, online-banking, information collection about products, health-related topics, software downloads, dictionaries</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient's internet use for health-related topics</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluated in the following criteria: does the patient use the internet for health-related topics and if yes, for what exactly</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient's technical equipment</measure>
    <time_frame>3 months</time_frame>
    <description>The presence of following equipment was evaluated: fixed network telephone, smartphone, internet-enabled computer, notebook, laptop, iPad and tablet ownership.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>eHealth usage satisfaction</measure>
    <time_frame>3 months</time_frame>
    <description>By a structured interview with the patients about their user satisfaction (graded between 1 (best) and 5 (worst))</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Multiple Myeloma</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>eHealth platform CANKADO</intervention_name>
    <description>The patients were asked to use the open eHealth platform CANKADO as a digital supporting tool.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        30 patients (median age 75 years) suffering from multiple myeloma treated by oral IMiDs in
        8 medical centers were asked to use the open eHealth platform CANKADO as a digital
        therapy-supporting tool.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  multiple myeloma patients

          -  treated by oral IMiDs

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timo Schinköthe, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cankado Service GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hämato-Onkologische Schwerpunktpraxis</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.-Antonius-Hospital</name>
      <address>
        <city>Eschweiler</city>
        <zip>52249</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis am Albertinen- Krankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22457</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut für Versorgungsforschung in der Onkologie GbR</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onkologie-Köln,</name>
      <address>
        <city>Köln</city>
        <zip>50677</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie und Onkologie</name>
      <address>
        <city>Langen</city>
        <zip>63225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. med. Peter Ehscheidt, Facharzt für Innere Medizin, Hämatologie, Onkologie, Medikamentöse Tumortherapie und Palliativmedizin</name>
      <address>
        <city>Neuwied</city>
        <zip>56564</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medicum</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

